P. Boyle
Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

P. Autier
Centre for Research on Epidemiology and Health Information Systems (CRESIS), Centre de Recherche Public de la Santé, Luxembourg.

H. Bartelink
Professor and Chairman, Radiotherapy Department, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam, The Netherlands.

J. Baselga
Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron, Barcelona, Spain.

P. Boffett
Chief, Unit of Environmental Cancer Epidemiology, International Agency for Research on Cancer, Lyon, France.

J. Burn
Cancer Family Network, CancerResearchUK, University of
Newcastle, Newcastle, UK.

H. J. G. Burns
Chief Administrative Medical Officer, Greater Glasgow Health Board, Glasgow, UK.

L. Christensen
President, The Association of European Cancer Leagues, Oslo, Norway.

L. Denis
Oncology Centre Antwerp, Antwerp, Belgium.

M. Dicato
Hematology-Oncology, Centre Hospitalier, Luxembourg.

V. Diehl
Med. Klinic 1, Universitat zuKoln, Koln, Germany.

R. Doll
Clinical Trial Service Unit, Cancer Research UK Cancer Studies Unit, Radcliffe Infirmary, Oxford, UK.

S. Franceschi
Chief, Field and Intervention StudiesUnit, IARC, Lyon, France.

C. R. Gillis
Scientific Coordinator, Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

N. Gray
Department of
Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

L. Griciute
Lithuanian Oncology Center, Vilnius, Lithuania.

A. Hackshaw
Deputy Director, Cancer ResearchUK & UCL Cancer Trials Centre, Stephenson House, London, UK.

M. Kasler
Director, National Institute of Oncology, Budapest, Hungary.

M. Kogevinas
Department of Epidemiology andPublic Health, Institut Municipal d’Investigacio Mèdica (IMIM), Barcelona, Spain.

S. Kvinnsland
Department of Oncology, Haukaland Hospital, Bergen, Norway.

C. La Vecchia
Istituto diRicerche Farmacologiche Mario Negri, Milan, Italy.

F. Levi
Director, Registre Vaudois des Tumeurs, Institut Universitaire de Médecine Sociale et Préventive, Lausanne,Switzerland.

J. G. McVie
Scientific Coordinator, Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

P. Maisonneuve
Unit of Clinical Epidemiology,Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.

J. M. Martin-Moreno
Director-General of Public Health, Ministerio de Sanidad y Consumo,Madrid, Spain.

J. Newton Bishop
Genetic Epidemiology Division, Cancer Research UK, St James’s University Hospital, Leeds, UK.

F. Oleari
Ministero della Sanita’, Roma, Italy.

P. Perrin
Chairman,Department of Urology, Hopital de l’Antiquaille, Lyon, France.

M. Quinn
Director, National Cancer Intelligence Centre, Office for National Statistics, B6/02, 1 Drummond
Gate, London, UK.

M. Richards
National Cancer Director, St Thomas’ Hospital, London, UK.

U. Ringborg
Department of Oncology, Radiumhemmet, Karolinska Hospital, Stockholm.

C. Scully
Dean and Director of Studies and Research, Eastman Dental Institute for Oral Health Care Sciences and International Centres for Excellence in Dentistry,University of London, Eastman Dental Institute, London, UK.

E. Siracka
President, Liga proti rakovine SR, Bratislava, Slovakia.

H. Storm
Danish Cancer Society, Director CancerPrevention and Documentation, Copenhagen, Denmark.

M. Tubiana
President du Centre Antoine Beclere, Centre Antoine Beclere, Faculte’ de Medicine, Paris, France.

T. Tursz
Director, Institut Gustave Roussy, Villejuif, France.

U. Veronesi
Scientific Director, European Institute of Oncology, Milan, Italy.

N. Wald
The Medical College of St Bartholomew’s Hospital, Wolfson Institute of Preventive Medicine, Department of Epidemiology, London, UK.

W. Weber
Schweizerische Krebsliga, Berne, Switzerland.

D. G. Zaridze
Director, Institute of Carcinogenesis, Deputy Director, Cancer Research Centre RAMS, Moscow, Russian Federation.

W. Zatonski
Department of Cancer Epidemiology and Prevention, The Marie-Sklodowska Memorial, Cancer Center and Institute of Oncology, Warsaw, Poland.

H. zur Hausen
Director, German Cancer Research Center (DKFZ), Heidelberg, Germany.